MedPath

Onetazid

Brand Name: Onetazid

Generic Name: Ceftazidime (as pentahydrate)

Expiring Soon
Registration Number

DRP-2733-02

Dosage Form

Powder For Injection (IM/IV)

Issuance Date

September 1, 2020

Expiry Date

January 18, 2026

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength1 g
PackagingUSP Type I Clear Glass Vial (Box of 10's)

Classification

C
Classification
Prescription Drug (RX)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Ceftazidime (as pentahydrate)Active
Monograph: ceftazidime (as pentahydrate)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform